文献速递皮肤肿瘤

澳大利亚雀斑样黑素瘤十年随访:临床病理特征、管理与复发率

Lentiginous melanoma (lentigo maligna and lentigo maligna melanoma) in Australia: clinicopathological characteristics, management and recurrence rates after 10-year follow-up at a tertiary centre.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2021-03-03

随访期间复发率为38%,复发患者半数在首次治疗后3.8年内出现,提示需长期监测。

要点

  • LM/LMM临床边界多不清,复发灶常缺乏黑素瘤皮肤镜特征。
  • 中位随访7.5年期间复发率达38%,需长期随访。
  • 复发患者半数在首次治疗后3.8年内出现,早期监测关键。

核心结论

  • LM/LMM常晚期复发且临床表现隐匿,需要仔细监测和长期随访。

主要发现

  • 原发性病例多数色素性(71%),复发灶77%为部分色素/浅棕色或无色素性。
  • 临床边界不清见于64%原发性病例和94%复发灶。
  • 原发性LM/LMM皮肤镜显示经典「普通」黑素瘤特征者占33%,经典LM/LMM特征者占41%;复发灶95%无黑素瘤或LM/LMM特征。
  • 初诊即切除的原发性病例113处(97%),组织病理学平均清晰切缘4.9 mm(范围0.1–22 mm)。

临床怎么用

  • 对LM/LMM患者应进行长期随访和仔细监测,尤其关注复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lentiginous melanoma or lentigo maligna is a slow-growing type of melanoma frequently arising in sun-damaged skin and often first diagnosed in the elderly. Few studies report long-term follow-up. OBJECTIVES: To define characteristics of lentiginous melanoma in situ (LM) and invasive lentiginous melanoma (LMM) in Australian patients managed at a tertiary centre and describe local recurrence or treatment failure rates after long-term follow-up. METHODS: Retrospective single-centre study of LM/LMM patients evaluated between January 2005 and March 2007. Medical and photographic records were reviewed. RESULTS: One hundred two patients were included, with a total of 117 lesions (70 LM and 47 LMM). Seventy-nine were new primary LM/LMM, and 38 were recurrences. Primary cases were mostly pigmented (71%), while 77% of recurrent cases were partially pigmented/light brown or amelanotic. The margins were clinically ill-defined in the majority of cases (64% of primary cases and 94% of recurrent cases). Dermoscopy of the primary LM/LMM showed either classic 'common' melanoma features (33%) or classic LM/LMM features (41%), while 95% of recurrent cases had no features for melanoma or LM/LMM. Primary cases that were initially excised (113, 97%) had mean histopathological clear margins of 4.9 mm (range 0.1-22 mm). The median follow-up time was 7.5 years (95% CI 5.2-10.0) with more than 10-year follow-up in 32% and 5-10 years in 24% of patients. There were 44 (38%) recurrences over the entire follow-up period. Half of the patients who recurred did so within the first 3.8 years after the first treatment. CONCLUSION: LM/LMM often recur late and are clinically subtle; therefore, careful monitoring and long-term follow-up are required.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Collgros H, Rodriguez-Lomba E, Regio Pereira A, et al. Lentiginous melanoma (lentigo maligna and lentigo maligna melanoma) in Australia: clinicopathological characteristics, management and recurrence rates after 10-year follow-up at a tertiary centre. J Eur Acad Dermatol Venereol. 2021. PMID: 33502077. doi:10.1111/jdv.17135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。